Acadian Asset Management’s PharMerica Corporation PMC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-53
Closed -$1K 1908
2016
Q4
$1K Buy
+53
New +$1.34K ﹤0.01% 1616
2016
Q1
Sell
-144,625
Closed -$5.06M 1580
2015
Q4
$5.06M Buy
+144,625
New +$4.53M 0.03% 396
2015
Q3
Sell
-9,156
Closed -$305K 1527
2015
Q2
$305K Buy
+9,156
New +$281K ﹤0.01% 863
2015
Q1
Sell
-236,491
Closed -$4.9M 1521
2014
Q4
$4.9M Sell
236,491
-705,069
-75% -$16.7M 0.02% 406
2014
Q3
$23M Sell
941,560
-259,289
-22% -$6.88M 0.11% 190
2014
Q2
$34.3M Buy
1,200,849
+28,045
+2% +$780K 0.17% 155
2014
Q1
$32.8M Sell
1,172,804
-18,880
-2% -$464K 0.17% 134
2013
Q4
$25.6M Buy
1,191,684
+7,288
+0.6% +$132K 0.14% 146
2013
Q3
$15.7M Buy
1,184,396
+63,896
+6% +$861K 0.1% 182
2013
Q2
$15.5M Buy
+1,120,500
New +$15.9M 0.11% 168

Other funds holding PMC

Acadian Asset Management's PMC Position: Q1 2017 in Review

Acadian Asset Management sold out of PharMerica Corporation (PMC) in Q1 2017, closing a stake of 53 shares — an estimated $1K sold.

Acadian Asset Management first reported a position in PMC in Q2 2013 and held it in 10 quarters. The position peaked at $34.3M in Q2 2014. 152 funds tracked by Wall St. Rank hold PMC as of Q1 2017.

  • Acadian Asset Management reported no remaining PharMerica Corporation position as of Q1 2017 after selling out during the quarter.
  • Acadian Asset Management sold 53 PharMerica Corporation shares in Q1 2017, an estimated $1K.
  • Acadian Asset Management first reported a position in PharMerica Corporation in Q2 2013 and held it in 10 quarters.
  • Acadian Asset Management's PharMerica Corporation position peaked at $34.3M in Q2 2014.
  • 152 funds tracked by Wall St. Rank held PharMerica Corporation as of Q1 2017.

Based on Acadian Asset Management's 13F filing for Q1 2017, filed 25 Apr 2017.